Thursday, September 3, 2009
Abbott to Acquire Visiogen for $400 Million Cash - Bloomberg
RTT NewsAbbott to Acquire Visiogen for $400 Million CashBloomberg2 (Bloomberg) -- Abbott Laboratories said it agreed to acquire Irvine, California-based Visiogen Inc., a maker of artificial lenses used to treat patients ...Abbott to Acquire Visiogen, Expanding Vision Care PortfolioReutersAbbott acquires Visiogen for $400MThe Associated PressAbbott Labs to acquire Visiogen for $400 millionMarketWatchOrange County Business Journal -socalTech.com -Reutersall 97 news articles »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment